The global prepacked chromatography columns market is extremely consolidated in nature, with the top two players, namely GE Healthcare and Repligen, commanding 78.0% of the overall market in 2015. According to a report by Transparency Market Research (TMR), GE alone accounted for whopping 54.0% of the market in the same year.
“Mergers and acquisitions and product innovation are the key strategies adopted by these players to maintain their leadership in the market,” says the author of the report. For instance, with the acquisition of Atoll, Repligen is expected to cover a larger share in the market in the forthcoming years. The valuation of the global prepacked chromatography columns market was US$1.74 bn in 2016 and is poised to reach US$3.34 bn by 2024, expand at a CAGR of 8.4% therein.
Asia Pacific to Surpass North America by End of Forecast Period
Hydrophobic stationary phase will continue to be the most prominent technology segment until 2024, representing 72.8% of the overall market revenue. Growing investments and funding along with an uptick in research and development activities in the life sciences, biotechnology, and pharmaceutical sectors are contributing to the growth of the segment. On the other hand, multimodal chromatography is expected to register a CAGR higher than any other segment during the review period.
Geographically, North America was the frontrunner in the global prepacked market in terms of revenue in 2016. However, Asia Pacific is anticipated to overtake the revenue contribution of the region towards the end of the forecast period. The growing investments by international players and improving scenario for research and development activities are providing a significant momentum to the market in the region. Owing to these factors, the region is estimated to progress at a CAGR of 10.2% during the same period.
Growing Need for Purification of Biopharmaceutical Drugs Triggers Demand for Prepacked Chromatography Columns
It is necessary for biopharmaceuticals drugs to have exceptional purity. This makes screening and purification a critical component in the manufacturing process of these drugs. The spiraling sales of statins, vaccines, and therapeutics is translating into the greater need for purification. “The acceptance of prepacked chromatography columns in the purification process in the biopharmaceutical industry is growing at a brisk pace,” says a TMR analyst. Therefore, the global prepacked chromatography market is experiencing steady growth.
The number of monoclonal antibodies (mAbs) that are currently under clinical trial or have already been approved has increased significantly over the past few years. mAbs are used for the treatment of various diseases such as cancer, autoimmune diseases, and allergic diseases. The rising prevalence of these diseases is leading to the increasing demand for therapeutic mAbs, which in turn is escalating the development of the market.
Moreover, government organizations, particularly of developed countries, are increasing investments, funds, and grants to encouraging the development of drugs and biologics. This coupled with the growing research and development activities is stirring up the demand for prepacked chromatography column.
Economic Slowdown and High Costs of Prepacked Chromatography Columns Hamper Growth Prospects
The aftermath of the great recession in 2008 can be still felt on government budgets and available funding for the healthcare sector. The turbulence caused in the healthcare sector can also be felt in its affiliated markets and therefore, the global chromatography columns market. Besides this, the presence of a large number of players is resulting in an intense price war, which is leading to the high costs of chromatography columns. This is, thereby, hampering the growth of the market. Furthermore, the phenomena of fouling and clogging in columns are limiting their widespread adoption across different end-user industries.
The above data has been derived from a report by TMR, titled “Prepacked Chromatography Columns Market: (Product Type - 1-100 ml, 100-1000 ml, and >1L; Technique - Hydrophobic Stationary Phase, Ion Exchange Chromatography, Affinity Chromatography, Multimodal Chromatography, Gel Filtration; Application Type - Sample Preparation, Resin Screening, Protein Purification, Anion and Cation Exchange, and Desalting; End-user - Pharmaceutical Biotechnology, Food and Beverage, Agriculture and Environmental, Nutraceutical, Academics and Research, and Analytical Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
The prepacked chromatography columns market has been segmented as follows:
Global Prepacked Chromatography Columns Market, by Product Type
Global Prepacked Chromatography Columns Market, by Technique
Global Prepacked Chromatography Columns Market, by Application
Global Prepacked Chromatography Columns Market, by End-user
Global Prepacked Chromatography Columns Market, by Region
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453